Imatinib/pazopanibCholestasis and lack of efficacy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1953卷 / 1期

关键词：

D O I：

10.1007/s40278-023-37641-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：206 / 206

相关论文

共 50 条

[1] Dasatinib/imatinib/ponatinibRash and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1913 (1) : 173 - 173
[2] Imatinib/ipilimumab/nivolumabVarious toxicities, lack of efficacy and off label use: 4 case reports
Reactions Weekly, 2023, 1960 (1) : 226 - 226
[3] GanciclovirNeutropenia and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1935 (1) : 208 - 208
[4] WarfarinNosebleed and lack of efficacy: 4 case reports
Reactions Weekly, 2021, 1878 (1) : 512 - 512
[5] EverolimusHyperlipidaemia and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1971 (1) : 117 - 117
[6] Imatinib/nilotinibCytopenia, drug withdrawal syndrome and lack of efficacy: 26 case reports
Reactions Weekly, 2023, 1954 (1) : 236 - 236
[7] AntineoplasticsVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1983 (1) : 63 - 63
[8] NivolumabThyroid dysfunction and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1917 (1) : 456 - 456
[9] AntineoplasticsDRESS syndrome and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1917 (1) : 73 - 73
[10] Multiple drugsMyocarditis and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1944 (1) : 409 - 409

← 1 2 3 4 5 →